 |
 |
|
|
|  PubMed
|
| |||||||||||||||||||||||||||||||||||||||||||||||
20 February 2007 | Volume 146 Issue 4 | Pages 233-243
Background: It is not known whether rigorous intraoperative glycemic control reduces death and morbidity in cardiac surgery patients.
Objective: To compare outcomes of intensive insulin therapy during cardiac surgery with those of conventional intraoperative glucose management.
Design: A randomized, open-label, controlled trial with blinded end point assessment.
Setting: Tertiary care center.
Patients: Adults with and without diabetes who were undergoing on-pump cardiac surgery.
Measurements: The primary outcome was a composite of death, sternal infections, prolonged ventilation, cardiac arrhythmias, stroke, and renal failure within 30 days after surgery. Secondary outcome measures were length of stay in the intensive care unit and hospital.
Intervention: Patients were randomly assigned to receive continuous insulin infusion to maintain intraoperative glucose levels between 4.4 (80 mg/dL) and 5.6 mmol/L (100 mg/dL) (n = 199) or conventional treatment (n = 201). Patients in the conventional treatment group were not given insulin during surgery unless glucose levels were greater than 11.1 mmol/L (>200 mg/dL). Both groups were treated with insulin infusion to maintain normoglycemia after surgery.
Results: Mean glucose concentrations were statistically significantly lower in the intensive treatment group at the end of surgery (6.3 mmol/L [SD, 1.6] [114 mg/dL {SD, 29}] in the intensive treatment group vs. 8.7 mmol/L [SD, 2.3] [157 mg/dL {SD, 42}] in the conventional treatment group; difference, –2.4 mmol/L [95% CI, –2.8 to –1.9 mmol/L] [–43 mg/dL {CI, –50 to –35 mg/dL}]). Eighty two of 185 patients (44%) in the intensive treatment group and 86 of 186 patients (46%) in the conventional treatment group had an event (risk ratio, 1.0 [CI, 0.8 to 1.2]). More deaths (4 deaths vs. 0 deaths; P = 0.061) and strokes (8 strokes vs. 1 strokes; P = 0.020) occurred in the intensive treatment group. Length of stay in the intensive care unit (mean, 2 days [SD, 2] vs. 2 days [SD, 3]; difference, 0 days [CI, –1 to 1 days]) and in the hospital (mean, 8 days [SD, 4] vs. 8 days [SD, 5]; difference, 0 days [CI, –1 to 0 days]) was similar for both groups.
Limitations: This single-center study used a composite end point and could not examine whether outcomes differed by diabetes status.
Conclusions: Intensive insulin therapy during cardiac surgery does not reduce perioperative death or morbidity. The increased incidence of death and stroke in the intensive treatment group raises concern about routine implementation of this intervention.
Editors' Notes
Context
Contributions
Caution
Implications
—The Editors
Author and Article Information
From the Mayo Clinic College of Medicine, Rochester, Minnesota.
ClinicalTrials.gov registration number: NCT00282698.
Acknowledgments: The authors thank Nicole Henderson, Laurie Olsen, and Lisa Schrader for recruitment of study participants, data collection and entry, and project management; Victor Montori, MD, MSc, for providing methodological expertise; and Darrell Schroeder, MS, for statistical support.
Potential Financial Conflicts of Interest: Consultancies: R.A. Rizza (Abbott, Takeda, Symphony Capital, Eli Lilly Inc.), M.M. McMahon (Baxter Healthcare); Honoraria: R.A. Rizza (Merck & Co. Inc., Novo Nordisk, Takeda, Mankind, Eli Lilly Inc.); Stock ownership or options (other than mutual funds): R.A. Rizza (Diobex); Grants received: H.V. Schaff (AstraZeneca, Atricure Inc., Avant Immunotherapeutics Inc., Baxter, Boston Scientific, Cryolife Inc., Edwards Lifesciences, Jarvik Heart Inc., Medtronic Inc., Sorin Group/Carbomedics, St. Jude Medical, Thoratec Corporation, TransTech Pharma Inc., W.L. Gore and Associates Inc.).
Requests for Single Reprints: Gunjan Y. Gandhi, MD, MSc, Mayo Clinic College of Medicine, 200 First Street Southwest, Rochester, MN 55905; e-mail, gandhi.gunjan{at}mayo.edu.
Current Author Addresses: Drs. Gandhi, Nuttall, Abel, Mullany, Schaff, O'Brien, Williams, Rizza, and McMahon; Mr. Johnson, Ms. Cutshall, and Ms. Mundy: Mayo Clinic College of Medicine, 200 First Street Southwest, Rochester, MN 55905.
Author Contributions: Conception and design: G.Y. Gandhi, G.A. Nuttall, M.D. Abel, P.C. O'Brien, A.R. Williams, S.M. Cutshall, L.M. Mundy, R.A. Rizza, M.M. McMahon.
Analysis and interpretation of the data: G.Y. Gandhi, G.A. Nuttall, P.C. O'Brien, R.A. Rizza, M.M. McMahon.
Drafting of the article: G.Y. Gandhi, R.A. Rizza, M.M. McMahon.
Critical revision of the article for important intellectual content: G.Y. Gandhi, G.A. Nuttall, M.D. Abel, C.J. Mullany, P.C. O'Brien, A.R. Williams, R.A. Rizza, M.M. McMahon.
Final approval of the article: G.Y. Gandhi, R.A. Rizza, M.M. McMahon.
Provision of study materials or patients: C.J. Mullany, H.V. Schaff.
Statistical expertise: P.C. O'Brien, M.G. Johnson.
Obtaining of funding: A.R. Williams, R.A. Rizza, M.M. McMahon.
Administrative, technical, or logistic support: G.A. Nuttall, M.D. Abel, C.J. Mullany, H.V. Schaff, S.M. Cutshall, L.M. Mundy.
Collection and assembly of data: G.Y. Gandhi. ARTICLE
Intensive Intraoperative Insulin Therapy versus Conventional Glucose Management during Cardiac Surgery
A Randomized Trial
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Facebook 
Reddit 
Technorati 
Twitter What's this?
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  E. S. Moghissi, M. T. Korytkowski, M. DiNardo, D. Einhorn, R. Hellman, I. B. Hirsch, S. E. Inzucchi, F. Ismail-Beigi, M. S. Kirkman, and G. E. Umpierrez American Association of Clinical Endocrinologists and American Diabetes Association Consensus Statement on Inpatient Glycemic Control Diabetes Care, June 1, 2009; 32(6): 1119 - 1131. [Full Text] [PDF]
|
|
|
|
 |
|
 R. P. Olson, M. A. Bethel, and L. Lien Preoperative Hypoglycemia in a Patient Receiving Insulin Detemir Anesth. Analg., June 1, 2009; 108(6): 1836 - 1838. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Szabo, R. G. G. Andersson, and H. J. Arnqvist Intraoperative muscle and fat metabolism in diabetic patients during coronary artery bypass grafting surgery: a parallel microdialysis and organ balance study Br. J. Anaesth., May 19, 2009; (2009) aep105v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Blaha, P. Kopecky, M. Matias, R. Hovorka, J. Kunstyr, T. Kotulak, M. Lips, D. Rubes, M. Stritesky, J. Lindner, et al. Comparison of Three Protocols for Tight Glycemic Control in Cardiac Surgery Patients Diabetes Care, May 1, 2009; 32(5): 757 - 761. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. L. Lazar, M. McDonnell, S. R. Chipkin, A. P. Furnary, R. M. Engelman, A. R. Sadhu, C. R. Bridges, C. K. Haan, R. Svedjeholm, H. Taegtmeyer, et al. The society of thoracic surgeons practice guideline series: blood glucose management during adult cardiac surgery. Ann. Thorac. Surg., February 1, 2009; 87(2): 663 - 669. [Full Text] [PDF]
|
|
|
|
|
|
D. Sharma, J. Jelacic, R. Chennuri, O. Chaiwat, W. Chandler, and M. S. Vavilala Incidence and Risk Factors for Perioperative Hyperglycemia in Children with Traumatic Brain Injury Anesth. Analg., January 1, 2009; 108(1): 81 - 89. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Wiener, D. C. Wiener, and R. J. Larson Benefits and Risks of Tight Glucose Control in Critically Ill Adults: A Meta-analysis JAMA, August 27, 2008; 300(8): 933 - 944. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Albacker, G. Carvalho, T. Schricker, and K. Lachapelle High-Dose Insulin Therapy Attenuates Systemic Inflammatory Response in Coronary Artery Bypass Grafting Patients Ann. Thorac. Surg., July 1, 2008; 86(1): 20 - 27. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Lecomte, L. Foubert, F. Nobels, J. Coddens, G. Nollet, F. Casselman, P. V. Crombrugge, G. Vandenbroucke, and G. Cammu Dynamic Tight Glycemic Control During and After Cardiac Surgery Is Effective, Feasible, and Safe Anesth. Analg., July 1, 2008; 107(1): 51 - 58. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Gandhi, B. A. Finegan, and A. S. Clanachan Role of glucose metabolism in the recovery of postischemic LV mechanical function: effects of insulin and other metabolic modulators Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2576 - H2586. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-C. Lacherade, H. Outin, B. De Jonghe, D. Bracco, T. Schricker, G. Carvalho, L. Muller, S. Jaber, J. Y. Lefrant, G. Van den Berghe, et al. Insulin and Pentastarch for Severe Sepsis N. Engl. J. Med., May 8, 2008; 358(19): 2071 - 2075. [Full Text] [PDF]
|
|
|
|
 |
|
 T. Doenst, H. Bugger, M. Schwarzer, G. Faerber, M. A. Borger, and F. W. Mohr Three good reasons for heart surgeons to understand cardiac metabolism Eur. J. Cardiothorac. Surg., May 1, 2008; 33(5): 862 - 871. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Fowler, N. K. J. Adhikari, D. C. Scales, W. L. Lee, and G. D. Rubenfeld Update in Critical Care 2007 Am. J. Respir. Crit. Care Med., April 15, 2008; 177(8): 808 - 819. [Full Text] [PDF]
|
|
|
|
|
|
C. J. Zuurbier, F. J. Hoek, J. van Dijk, N. G. Abeling, J. C. M. Meijers, J. H. M. Levels, E. de Jonge, B. A. de Mol, and H. B. Van Wezel Perioperative hyperinsulinaemic normoglycaemic clamp causes hypolipidaemia after coronary artery surgery Br. J. Anaesth., April 1, 2008; 100(4): 442 - 450. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. D. Evans and Y. Niu Hypolipidaemic effects of high-dose insulin therapy Br. J. Anaesth., April 1, 2008; 100(4): 429 - 433. [Full Text] [PDF]
|
|
|
|
 |
|
 G. Y. Gandhi, M. H. Murad, D. N. Flynn, P. J. Erwin, A. B. Cavalcante, H. B. Nielsen, S. E. Capes, K. Thorlund, V. M. Montori, and P. J. Devereaux Effect of Perioperative Insulin Infusion on Surgical Morbidity and Mortality: Systematic Review and Meta-analysis of Randomized Trials Mayo Clin. Proc., April 1, 2008; 83(4): 418 - 430. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. L. Jensen Inflammation: An Expanding Universe Nutr Clin Pract, February 1, 2008; 23(1): 1 - 2. [Full Text] [PDF]
|
|
|
|
 |
|
 Z. I. Khalpey, R. B. Ganim, and J. D. Rawn Postoperative Care of Cardiac Surgery Patients Card. Surg. Adult, January 1, 2008; 3(2008): 465 - 486. [Full Text]
|
|
|
|
 |
|
 R. Assaly and R. H. Habib Intensive Intraoperative Insulin Therapy versus Conventional Glucose Management during Cardiac Surgery Ann Intern Med, October 2, 2007; 147(7): 521 - 521. [Full Text] [PDF]
|
|
|
|
|
|
G. Carvalho and T. Schricker Intensive Intraoperative Insulin Therapy versus Conventional Glucose Management during Cardiac Surgery Ann Intern Med, October 2, 2007; 147(7): 520 - 521. [Full Text] [PDF]
|
|
|
|
|
|
F. Rius and D. Mauricio Intensive Intraoperative Insulin Therapy versus Conventional Glucose Management during Cardiac Surgery Ann Intern Med, October 2, 2007; 147(7): 521 - 521. [Full Text] [PDF]
|
|
|
|
 |
|
 G. Thomas, M. C. Rojas, S. K. Epstein, E. M. Balk, O. Liangos, and B. L. Jaber Insulin therapy and acute kidney injury in critically ill patients a systematic review Nephrol. Dial. Transplant., October 1, 2007; 22(10): 2849 - 2855. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. Reich and G. W. Fischer Perioperative Interventions to Modify Risk of Morbidity and Mortality Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2007; 11(3): 224 - 230. [Abstract] [PDF]
|
|
|
|
 |
|
 Additional articles abstracted in ACP Journal Club Evid. Based Med., August 1, 2007; 12(4): 126 - 126. [Full Text] [PDF]
|
|
|
|
|
|
E. A. Martinez and P. J. Pronovost Thinking Like A Pancreas: A Look Ahead at Diabetes Technology in the Perioperative Setting Anesth. Analg., August 1, 2007; 105(2): 545 - 546. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Pignone Intraoperative Intensive Insulin Therapy Did Not Improve Outcomes Among Patients Undergoing Cardiac Surgery Clin. Diabetes, July 1, 2007; 25(3): 98 - 98. [Full Text] [PDF]
|
|
|
|
 |
|
 Tight Glycemic Control During Cardiac Surgery: No Benefit Journal Watch (General), March 15, 2007; 2007(315): 3 - 3. [Full Text]
|
|
|
|
|
|
G. Van den Berghe Does Tight Blood Glucose Control during Cardiac Surgery Improve Patient Outcome? Ann Intern Med, February 20, 2007; 146(4): 307 - 308. [Full Text] [PDF]
|
|
Read all Rapid Responses
